Aclidinium bromide for the treatment of chronic obstructive pulmonary disease

@article{Cazzola2013AclidiniumBF,
  title={Aclidinium bromide for the treatment of chronic obstructive pulmonary disease},
  author={M. Cazzola and C. Page and M. Matera},
  journal={Expert Opinion on Pharmacotherapy},
  year={2013},
  volume={14},
  pages={1205 - 1214}
}
  • M. Cazzola, C. Page, M. Matera
  • Published 2013
  • Medicine
  • Expert Opinion on Pharmacotherapy
  • Introduction: Although there are some challenges with current therapies, the growing evidence that tiotropium bromide is important in the maintenance treatment of chronic obstructive pulmonary disease (COPD) has led to enthusiastic investigation in search of novel muscarinic antagonists which share some of the beneficial characteristics of tiotropium and perhaps improve upon less desirable ones. Areas covered: Aclidinium bromide is a new muscarinic antagonist that has been developed to relieve… CONTINUE READING
    6 Citations

    References

    SHOWING 1-10 OF 60 REFERENCES
    Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease
    • 30
    Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease
    • 78
    • Highly Influential
    • PDF
    Safety and pharmacokinetics of multiple doses of aclidinium bromide administered twice daily in healthy volunteers.
    • 24
    Aclidinium bromide provides long-acting bronchodilation in patients with COPD.
    • 57
    • PDF
    Aclidinium bromide, a novel long-acting muscarinic M3 antagonist for the treatment of COPD.
    • M. Cazzola
    • Medicine
    • Current opinion in investigational drugs
    • 2009
    • 21
    Novel bronchodilators for the treatment of chronic obstructive pulmonary disease.
    • 77
    Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study
    • 176
    • Highly Influential
    • PDF